Genetic variations in GBA1 and LRRK2 genes: Biochemical and clinical consequences in Parkinson disease
Variants in the GBA1 and LRRK2 genes are the most common genetic risk factors associated with Parkinson disease (PD). Both genes are associated with lysosomal and autophagic pathways, with the GBA1 gene encoding for the lysosomal enzyme, glucocerebrosidase (GCase) and the LRRK2 gene encoding for the...
Main Authors: | Laura J. Smith, Chiao-Yin Lee, Elisa Menozzi, Anthony H. V. Schapira |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-08-01
|
Series: | Frontiers in Neurology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fneur.2022.971252/full |
Similar Items
-
Seventy-Two-Hour LRRK2 Kinase Activity Inhibition Increases Lysosomal GBA Expression in H4, a Human Neuroglioma Cell Line
by: Clara Ruz, et al.
Published: (2022-06-01) -
The Effect of p.G2019S Mutation in the LRRK2 Gene on the Activity of Lysosomal Hydrolases and the Clinical Features of Parkinson's Disease Associated with p.N370S Mutation in the GBA1 Gene
by: Tatiana S. Usenko, et al.
Published: (2024-01-01) -
The Future of Targeted Gene-Based Treatment Strategies and Biomarkers in Parkinson’s Disease
by: Alexia Polissidis, et al.
Published: (2020-06-01) -
Parkinson’s disease in a patient with GBA and LRRK2 covariants after acute hypoxic insult: a case report
by: Yuting Tang, et al.
Published: (2023-06-01) -
Transcriptome deregulation of peripheral monocytes and whole blood in GBA-related Parkinson’s disease
by: Giulietta Maria Riboldi, et al.
Published: (2022-08-01)